Indian pharmaceutical companies have been actively investing in the United States in 2025, focusing on acquisitions of facilities, products, and stakes in U.S.-based firms to expand manufacturing capabilities, enter new segments like biologics and biosimilars, and strengthen their global supply … Continue reading Key Investments By Indian Pharmaceutical Companies In The U.S. In 2025